A phase I clinical trial to investigate CG026806

Trial Profile

A phase I clinical trial to investigate CG026806

Phase of Trial: Phase I

Latest Information Update: 15 Jun 2016

At a glance

  • Drugs CG 806 (Primary)
  • Indications Haematological malignancies
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Jun 2016 New trial record
    • 08 Jun 2016 According to an Aptose Biosciences media release, the company plans to initiate this trial by mid-2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top